Host-directed therapies for infectious diseases: current status, recent progress, and future prospects-Reference-Cited by-同舟云学术

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

Published:2016-04 Issue:4 Volume:16 Page:e47-e63
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Zumla Alimuddin,Rao Martin,Wallis Robert S,Kaufmann Stefan H E,Rustomjee Roxana,Mwaba Peter,Vilaplana Cris,Yeboah-Manu Dorothy,Chakaya Jeremiah,Ippolito Giuseppe,Azhar Esam,Hoelscher Michael,Maeurer Markus

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference172 articles.

1. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013;Lancet,2015

2. Modulating immunity as a therapy for bacterial infections;Hancock;Nat Rev Microbiol,2012

3. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial;Blum;Lancet,2015

4. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock;Rodríguez;Crit Care Med,2007

5. Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia;Hanly;Lancet,1987

Cited by 266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking HXA ₃ -mediated neutrophil elastase release during S. pneumoniae lung infection limits pulmonary epithelial barrier disruption and bacteremia;mBio;2024-09-11

2. The aryl hydrocarbon receptor and FOS mediate cytotoxicity induced by Acinetobacter baumannii;Nature Communications;2024-09-11

3. Proapoptotic Bcl-2 inhibitor as host directed therapy for pulmonary tuberculosis;2024-09-02

4. Macrophage-targeted versus free calcitriol as host-directed adjunct therapy against Mycobacterium tuberculosis infection in mice is bacteriostatic and mitigates tissue pathology;Tuberculosis;2024-09

5. Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles;Frontiers in Immunology;2024-08-15